C12N 2501/59
Lectins
C12N2501/59 (Lectins) appears on 60 US grants and 98 published applications in this corpus.
Search patents in C12N- Granted patents
- 60
- Published applications
- 98
- Assignees
- 53
- Inventors
- 173
- Latest grant
- 3 Mar 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1980 | 1 | 0 |
| 1981 | 0 | 0 |
| 1982 | 0 | 0 |
| 1983 | 0 | 0 |
| 1984 | 0 | 0 |
| 1985 | 1 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 0 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 1 | 0 |
| 1998 | 3 | 0 |
| 1999 | 1 | 0 |
| 2000 | 0 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 5 |
| 2003 | 2 | 7 |
| 2004 | 2 | 5 |
| 2005 | 1 | 5 |
| 2006 | 3 | 1 |
| 2007 | 2 | 4 |
| 2008 | 1 | 6 |
| 2009 | 1 | 3 |
| 2010 | 3 | 5 |
| 2011 | 3 | 4 |
| 2012 | 1 | 4 |
| 2013 | 0 | 3 |
| 2014 | 5 | 1 |
| 2015 | 3 | 9 |
| 2016 | 8 | 3 |
| 2017 | 1 | 3 |
| 2018 | 3 | 7 |
| 2019 | 2 | 3 |
| 2020 | 0 | 2 |
| 2021 | 2 | 8 |
| 2022 | 2 | 4 |
| 2023 | 1 | 2 |
| 2024 | 2 | 1 |
| 2025 | 1 | 1 |
| 2026 | 1 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Methods for modulating macrophage activity3 Mar 2026US 12,564,617 B2Riptide Bioscience, Inc.
- Generating HPV antigen-specific T cells from a naïve T cell population25 Nov 2025US 12,478,670 B2Children's National Medical Center
- Compositions and methods for improving persistence of cells for adoptive transfer24 Dec 2024US 12,173,316 B2Celyad S.A.
- Generating HPV antigen-specific cells from a naive T cell population4 Jun 2024US 11,999,967 B2Children's National Medical Center
- Generating HPV antigen-specific cells from a naive T cell population16 May 2023US 11,649,437 B2Children's National Medical Center
- Methods for Modulating Macrophage Activity2 Jul 2026US 2026/0183362 A1Riptide Bioscience, Inc.
- Monoclonal antibody isolation26 Feb 2026US 2026/0055165 A1Imperial College Innovations Limited
- Compositions and methods for improving persistence of cells for adoptive transfer19 Jun 2025US 2025/0197805 A1Celyad S.A.
- Location-matched growth media formulations for the development of brain tumor organoids26 Dec 2024US 2024/0425822 A1
- Method for preparing universal immune cells and use thereof28 Sep 2023US 2023/0302132 A1
Most cited
By later US patents
- Enrichment by preferential mitosis of fetal lymphocytes from a maternal blood sample142US 5,716,776 A1998
- T cell differentiation of CD34+ stem cells in cultured thymic epithelial fragments61US 5,766,944 A1998
- Lymphoid tissue-specific cell production from hematopoietic progenitor cells in three-dimensional devices52US 7,192,769 B2Cytomatrix, LLC · 2007
- Human lineage committed cell composition with enhanced proliferative potential, biological effector function, or both; methods for obtaining same; and their uses49US 6,835,566 B2Aastrom Biosciences, Inc. · 2004
- Use of cytokines and mitogens to inhibit graft versus host disease43US 6,447,765 B1University of Southern California · 2002